Want to join the conversation?
$COST's comparable sales decreased 1% for 1Q16, with comparable sales from U.S. rose 2%, while that from Canada fell by 9% and other International sales declined 5%. Excluding negative impacts from gasoline price deflation and foreign exchange, comparable sales increased 6%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.